Sana Biotechnology Inc (SANA)
2.61
+0.26
(+11.06%)
USD |
NASDAQ |
Nov 22, 16:00
2.68
+0.07
(+2.68%)
After-Hours: 20:00
Sana Biotechnology Price to Book Value: 1.992 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 1.992 |
| November 21, 2024 | 1.794 |
| November 20, 2024 | 1.931 |
| November 19, 2024 | 1.802 |
| November 18, 2024 | 1.786 |
| November 15, 2024 | 1.847 |
| November 14, 2024 | 1.977 |
| November 13, 2024 | 2.031 |
| November 12, 2024 | 2.168 |
| November 11, 2024 | 2.206 |
| November 08, 2024 | 2.294 |
| November 07, 2024 | 2.366 |
| November 06, 2024 | 2.603 |
| November 05, 2024 | 2.588 |
| November 04, 2024 | 2.870 |
| November 01, 2024 | 2.794 |
| October 31, 2024 | 2.672 |
| October 30, 2024 | 2.792 |
| October 29, 2024 | 2.884 |
| October 28, 2024 | 2.990 |
| October 25, 2024 | 2.868 |
| October 24, 2024 | 2.906 |
| October 23, 2024 | 2.891 |
| October 22, 2024 | 2.975 |
| October 21, 2024 | 2.998 |
| Date | Value |
|---|---|
| October 18, 2024 | 3.227 |
| October 17, 2024 | 3.097 |
| October 16, 2024 | 3.227 |
| October 15, 2024 | 3.158 |
| October 14, 2024 | 3.059 |
| October 11, 2024 | 3.044 |
| October 10, 2024 | 2.922 |
| October 09, 2024 | 3.044 |
| October 08, 2024 | 3.112 |
| October 07, 2024 | 3.212 |
| October 04, 2024 | 3.227 |
| October 03, 2024 | 3.242 |
| October 02, 2024 | 3.326 |
| October 01, 2024 | 3.234 |
| September 30, 2024 | 3.173 |
| September 27, 2024 | 2.803 |
| September 26, 2024 | 2.797 |
| September 25, 2024 | 2.463 |
| September 24, 2024 | 2.679 |
| September 23, 2024 | 2.679 |
| September 20, 2024 | 2.784 |
| September 19, 2024 | 3.026 |
| September 18, 2024 | 2.810 |
| September 17, 2024 | 2.816 |
| September 16, 2024 | 2.856 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.075
Minimum
Dec 27 2022
8.641
Maximum
Mar 01 2024
3.112
Average
2.894
Median
Price to Book Value Benchmarks
| Foghorn Therapeutics Inc | -- |
| Omega Therapeutics Inc | 3.770 |
| Moderna Inc | 1.326 |
| Summit Therapeutics Inc | 32.00 |
| Apellis Pharmaceuticals Inc | 16.14 |
Price to Book Value Related Metrics
| Price | 2.61 |
| Earnings Yield | -53.64% |
| Market Cap | 582.73M |